FI64141C - Foerfarande foer framstaellning av nya terapeutiskt aktiva benso(c)kinolinderivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt aktiva benso(c)kinolinderivat Download PDF

Info

Publication number
FI64141C
FI64141C FI771550A FI771550A FI64141C FI 64141 C FI64141 C FI 64141C FI 771550 A FI771550 A FI 771550A FI 771550 A FI771550 A FI 771550A FI 64141 C FI64141 C FI 64141C
Authority
FI
Finland
Prior art keywords
methyl
benzo
hydroxy
compound
hydrogen
Prior art date
Application number
FI771550A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI64141B (fi
FI771550A (ja
Inventor
Michael Ross Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI771550A publication Critical patent/FI771550A/fi
Priority to FI820202A priority Critical patent/FI64142C/fi
Application granted granted Critical
Publication of FI64141B publication Critical patent/FI64141B/fi
Publication of FI64141C publication Critical patent/FI64141C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1782—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
FI771550A 1976-05-17 1977-05-16 Foerfarande foer framstaellning av nya terapeutiskt aktiva benso(c)kinolinderivat FI64141C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI820202A FI64142C (fi) 1976-05-17 1982-01-22 Foerfarande foer framstaellning av nya terapeutiskt aktiva benso(c)kinolinonderivat

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US68733276A 1976-05-17 1976-05-17
US68733276 1976-05-17
US75361976A 1976-12-22 1976-12-22
US75361976 1976-12-22
US77792877A 1977-03-15 1977-03-15
US77792877 1977-03-15

Publications (3)

Publication Number Publication Date
FI771550A FI771550A (ja) 1977-11-18
FI64141B FI64141B (fi) 1983-06-30
FI64141C true FI64141C (fi) 1983-10-10

Family

ID=27418484

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771550A FI64141C (fi) 1976-05-17 1977-05-16 Foerfarande foer framstaellning av nya terapeutiskt aktiva benso(c)kinolinderivat

Country Status (23)

Country Link
JP (1) JPS6016426B2 (ja)
AR (1) AR215896A1 (ja)
BG (4) BG28415A4 (ja)
CA (1) CA1095909A (ja)
CH (2) CH626881A5 (ja)
DD (1) DD130855A5 (ja)
DE (1) DE2722383A1 (ja)
DK (1) DK212677A (ja)
ES (4) ES458812A1 (ja)
FI (1) FI64141C (ja)
FR (2) FR2362129A1 (ja)
GR (1) GR74122B (ja)
IL (1) IL52087A (ja)
LU (1) LU77341A1 (ja)
NL (2) NL170141C (ja)
NO (1) NO147028C (ja)
NZ (1) NZ184114A (ja)
PH (1) PH16833A (ja)
PT (1) PT66550B (ja)
RO (1) RO76839A (ja)
SE (1) SE7704749L (ja)
SU (1) SU1098520A3 (ja)
YU (2) YU156882A (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2802211A1 (de) * 1978-01-19 1979-07-26 Basf Ag N-substituierte 2,6-dialkylaniline und verfahren zur herstellung von n- substituierten 2,6-dialkylanilinen
US4206225A (en) * 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4228169A (en) * 1979-06-26 1980-10-14 Pfizer Inc. 1,9-Dihydroxyoctahydrobenzo[c]quinolines and 1-hydroxyhexahydrobenzo[c]quinoline-9(8H)-ones as antiemetic agents
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
US4406888A (en) * 1981-01-09 1983-09-27 Pfizer Inc. Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
MX2011010058A (es) 2009-03-25 2011-10-11 Abbott Lab Compuestos antivirales y usos de los mismos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3649650A (en) * 1970-02-13 1972-03-14 Little Inc A Novel derivatives of tetrahydro-cannabinol
CA994791A (en) * 1971-05-12 1976-08-10 Louis S. Harris Esters of benzopyrans
US3856821A (en) * 1973-07-18 1974-12-24 Smithkline Corp ALKOXY DIBENZO (b,d) PYRANS
US3968125A (en) * 1973-11-05 1976-07-06 Eli Lilly And Company Dihydroxyhexahydrodibenzo[b,d]pyrans
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US3944673A (en) * 1973-11-05 1976-03-16 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as analgesic drugs
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor

Also Published As

Publication number Publication date
NO147028C (no) 1983-01-19
PT66550B (en) 1978-10-18
ES469203A1 (es) 1978-11-16
ES469202A1 (es) 1978-11-16
FR2362129B1 (ja) 1983-05-20
BG28416A4 (en) 1980-04-15
RO76839A (ro) 1981-05-30
ES458812A1 (es) 1978-08-16
NZ184114A (en) 1982-02-23
SU1098520A3 (ru) 1984-06-15
FR2362129A1 (fr) 1978-03-17
YU156982A (en) 1983-02-28
YU156882A (en) 1983-02-28
DE2722383C2 (ja) 1990-06-07
LU77341A1 (ja) 1977-12-13
SE7704749L (sv) 1977-12-05
BG28414A4 (en) 1980-04-15
NL170141C (nl) 1982-10-01
BG28415A4 (en) 1980-04-15
CA1095909A (en) 1981-02-17
ES469204A1 (es) 1978-11-16
CH628034A5 (en) 1982-02-15
DE2722383A1 (de) 1977-12-01
PT66550A (en) 1977-06-01
GR74122B (ja) 1984-06-06
DD130855A5 (de) 1978-05-10
AR215896A1 (es) 1979-11-15
JPS6016426B2 (ja) 1985-04-25
JPS52144672A (en) 1977-12-02
NO147028B (no) 1982-10-11
CH626881A5 (en) 1981-12-15
IL52087A0 (en) 1977-07-31
BG27897A3 (en) 1980-01-15
FI64141B (fi) 1983-06-30
IL52087A (en) 1981-11-30
NL7705433A (nl) 1977-11-21
NL7804461A (nl) 1978-08-31
FI771550A (ja) 1977-11-18
PH16833A (en) 1984-03-06
AU2516277A (en) 1978-06-22
NO771738L (no) 1977-11-18
DK212677A (da) 1977-11-18
FR2446284A1 (fr) 1980-08-08
FR2446284B1 (ja) 1983-08-26

Similar Documents

Publication Publication Date Title
US4888353A (en) Carboxamides useful as antiemetic or antipsychotic agents
EP0147044B1 (en) Benzofurancarboxamides, process for their preparation and pharmaceutical preparations containing them
US5482967A (en) Condensed heterocyclic compounds, their production and use
Gómez-Ayala et al. Synthesis, structural elucidation and in vitro antiparasitic activity against Trypanosoma cruzi and Leishmania chagasi parasites of novel tetrahydro-1-benzazepine derivatives
US5175173A (en) Carboxamides useful as antiemetic or antipsychotic agents
CS246085B2 (en) Method of dihydrobenzopyran's derivatives production
AU2416795A (en) Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists
AU600992B2 (en) Tetrahydroisoquinolin-2-yl derivatives of carboxylic acids
FI64141C (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva benso(c)kinolinderivat
JPS63277671A (ja) ３−アミノ−ジヒドロ−〔１〕−ベンゾピランおよびベンゾチオピラン
CA2126752C (en) Benzopyran and related ltb4 antagonists
CZ299598A3 (cs) Benzopyranové deriváty, způsob jejich výroby a farmaceutický prostředek
HU185133B (en) Process for producing 1-hydroxy-octahydro-benzo-bracket-c-bracket closed-quinolines and derivatives
JPH10504315A (ja) ５ｈｔ▲下１ｄ▼アンタゴニストとしてのビフェニルアミド誘導体
JP2001517646A (ja) ベンジルビフェニルおよび類似化合物、ならびに動脈硬化症および異脂肪血症を治療するためのそれらの適用
Kano et al. Formation of 2, 3-dihydro-4 (1 H)-quinolones and related compounds via Fries-type acid-catalysed rearrangement of 1-arylazetidin-2-ones
Hall et al. Quinoline derivatives as antiallergy agents. 2. Fused-ring quinaldic acids
Kanao et al. Spasmolytic agents. 2. 1, 2, 3, 4-Tetrahydro-2-naphthylamine derivatives
PL141640B1 (en) Method of obtaining novel derivatives of hexahydropyrol/1,2-a/quinoline,hexahydro-1h-pyrid/1,2-a/quinoline or octahydroxyphenathrene
JPS6023112B2 (ja) 新規なベンゾ〔ｃ〕キノリン類製造用中間体
US3629265A (en) 7-halo-4-isoquinolones
US5670667A (en) Chroman-2-ylmethylamino derivatives
KELKAR et al. Studies in Antifertility Agents
EP0135767A1 (en) Benzazepine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions
KR820001356B1 (ko) 벤조[c] 퀴놀린의 제조방법

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER INC.